Streetbeat News

Products Services

BMY

Bristol Myers Squibb (NYSE:BMY) has announced updated results from the TRIDENT-1 study, showing that repotrectinib, a next-generation ROS1/TRK tyrosine kinase inhibitor (TKI), continues to show high response rates and durable responses in patients with ROS1-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). The U.S. Food and Drug Administration has accepted the New Drug Application for repotrectinib and granted Priority Review. The data from the trial is expected to be presented at the IASLC 2023 World Conference on Lung Cancer.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 2:21 pm

AMZN

MAT

The 'Barbie' movie, which grossed over $1 billion at the box office, is set to arrive on digital on September 5 and is available for pre-order on Amazon for $19.99. The film, directed by Greta Gerwig and starring Margot Robbie, had the biggest opening weekend of 2023 and the best start for a film directed by a woman.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 2:15 pm

ADBE

Adobe Inc. has upgraded its cloud-based design platform, Adobe Express, with new AI features. The upgrade, which builds on Adobe Firefly's generative AI model, allows users to create custom images and text effects in over 100 languages. Additional enhancements include automatic background removal and audio-driven character animations. The upgraded Adobe Express is available on the desktop web for free, with a mobile version in the works. A premium subscription is available for $9.99/month, offering added features and design packs.

Portfolio Pulse from Sudhanshu Singh

August 16, 2023 | 2:09 pm

AZN

AstraZeneca has presented data at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC) that advances its ambition to have an AstraZeneca medicine for more than half of all patients treated for lung cancer by 2030. The data includes results from the FLAURA2 Phase III trial of Tagrisso, which has been granted Breakthrough Therapy Designation in the US, and results for Enhertu, Imfinzi and datopotamab deruxtecan. AstraZeneca is collaborating with Daiichi Sankyo Company Limited to develop and commercialise Enhertu and datopotamab deruxtecan, and with HUTCHMED to develop and commercialise Orpathys.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 2:09 pm

CMRX

Chimerix (NASDAQ:CMRX) has published data demonstrating the clinical efficacy of its first-in-class small molecule imipridone, ONC201, as a treatment for H3 K27M-mutant diffuse midline gliomas. The study showed a statistically significant increase in median overall survival (mOS) from diagnosis versus historical controls (21.7 months mOS vs. 12 months mOS). The company's CEO, Mike Andriole, stated that while these results require validation in prospectively designed studies, they provide ongoing confidence for ONC201's monotherapy treatment effect.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 2:07 pm

CAR

COIN

EMR

META

MSFT

OXY

TGT

TJX

TSEM

WBA

Elon Musk's X is accused of slowing traffic to sites criticized by him, including Instagram, owned by Meta Platforms Inc. Coinbase Global Inc has received federal approval for new futures offering. Tower Semiconductor Ltd's deal with Intel Corp has been terminated due to US-China tensions. Occidental Petroleum Corp is set to acquire Carbon Engineering Ltd for $1.1 billion. Emerson Electric Co is acquiring Flexim. Target Corp, TJX Companies Inc, and JD.com Inc have reported their Q2 earnings. Microsoft Corp's Game Pass is shaping the $60B gaming industry. Avis Budget Group Inc has been fined $275K for refusing to rent vehicles to customers without credit cards. Walgreens Boots Alliance Inc is facing a reopened lawsuit accusing it of Medicaid fraud.

Portfolio Pulse from Vandana Singh

August 16, 2023 | 2:01 pm

CVNA

Carvana Co. (NYSE:CVNA) has launched its newest Car Vending Machine in Hollywood near Miami-Dade and Fort Lauderdale. This is the second of its kind in the Miami area, the 38th in the U.S., and the fifth in Florida. The company's shares are trading lower by 1.17% to $38.86 on the last check Wednesday.

Portfolio Pulse from Nabaparna Bhattacharya

August 16, 2023 | 1:56 pm

AMZN

GOOG

MSFT

NVDA

ORCL

TSM

Nvidia Corp's stock traded higher on Wednesday, driven by its strong position in artificial intelligence. Analysts expressed confidence in the company's AI capabilities ahead of its 2Q results. Raymond James analyst Chris Caso maintained a Strong Buy rating and raised the price target from $450 to $500. Caso expects Nvidia to benefit from H100 ramps at Microsoft, Amazon, and Alphabet's Google. Demand from Oracle and specialty Cloud providers CoreWeave and Lambda also appears strong. In addition, Caso sees an inflection in Auto revenue in 2024 as agreements with Mercedes and JLR begin to ramp.

Portfolio Pulse from Anusuya Lahiri

August 16, 2023 | 1:46 pm

BYDDY

Chinese battery manufacturer, Contemporary Amperex Technology Co. Limited (CATL), has launched a fast-charging lithium iron phosphate (LFP) battery that can run 400 km on a 10-minute charge. The mass production of the new battery is expected by the end of 2024. CATL has been facing challenges with weak demand and a push from EV makers for cost reduction. The company has been losing ground to Chinese EV maker BYD Co., Ltd., which produces its own batteries.

Portfolio Pulse from Shivani Kumaresan

August 16, 2023 | 1:45 pm

TSLA

Tesla has reduced the prices of its Model S and Model X vehicles by $10,000 in a bid to attract more consumers and boost sales. This comes after a 13% decrease in Tesla's stock price in August, following a high of $299.29 in July. The stock's value has dropped by 22% from its peak, with the year-to-date gain now at 95%.

Portfolio Pulse from Zaheer Anwari

August 16, 2023 | 1:43 pm